RecruitingNot Applicable

Tegoprazan-containing Sequential for H. Pylori

South Korea400 participantsStarted 2021-02-01

Plain-language summary

As H. pylori eradication, the investigators prepared a randomized controlled clinical trial whether tegoprazan-containing 10-day sequential treatment was effective compared to conventional PPI-containing 10-day sequential eradication therapy

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients who had H. pylori infection proved by positive test result of urea breath test (UBT), rapid urase test or pathologic examination (warthin-giemsa staining) Exclusion Criteria: * congestive heart failure, NYHA III or IV * end-stage renal disease * alcoholics * drug abusers * pregnant or nursing women

What they're measuring

Eradication rate

Timeframe: 2 or 3 month

Trial details

NCT IDNCT06382493

SponsorSeoul National University Bundang Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-12

Contact for this trial

Jungwon Lee, Dr.

821093567758 saludos@naver.com

View on ClinicalTrials.gov More Helicobacter Pylori Infection trials